Samil Pharm (000520) — Cash Flow-to-Debt Ratio
Samil Pharm (000520) has a Cash Flow-to-Debt Ratio of 0.01x as of June 2025, meaning its operating cash flow of ₩2.44 Billion could theoretically repay 0% of its total liabilities (₩226.31 Billion) in one year. See Samil Pharm (000520) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Samil Pharm Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Samil Pharm across 13 annual periods. Also explore Samil Pharm (000520) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Samil Pharm (2012–2024)
Year-by-year debt coverage analysis for Samil Pharm. For market capitalisation and broader financial context, see market cap of Samil Pharm.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | ₩2.59 Billion | ₩218.95 Billion | ▼ -75.5% |
| 2023 | 0.05x | ₩11.75 Billion | ₩242.85 Billion | ▲ +168.8% |
| 2022 | 0.02x | ₩4.15 Billion | ₩230.88 Billion | ▲ +104.0% |
| 2021 | 0.01x | ₩1.42 Billion | ₩160.66 Billion | ▼ -85.5% |
| 2020 | 0.06x | ₩7.77 Billion | ₩128.11 Billion | ▼ -30.3% |
| 2019 | 0.09x | ₩10.59 Billion | ₩121.60 Billion | ▲ +405.2% |
| 2018 | -0.03x | ₩-2.62 Billion | ₩91.87 Billion | ▼ -163.5% |
| 2017 | 0.04x | ₩3.79 Billion | ₩84.31 Billion | ▼ -61.6% |
| 2016 | 0.12x | ₩5.63 Billion | ₩48.12 Billion | ▲ +80.0% |
| 2015 | 0.07x | ₩2.92 Billion | ₩44.90 Billion | ▲ +128.8% |
| 2014 | -0.23x | ₩-11.92 Billion | ₩52.88 Billion | ▼ -158.2% |
| 2013 | -0.09x | ₩-3.99 Billion | ₩45.68 Billion | ▼ -183.7% |
| 2012 | 0.10x | ₩5.02 Billion | ₩48.12 Billion | — |